CA2993407A1 — Ocular implants for reduction of intraocular pressure
Assigned to Glaukos Corp · Expires 2017-01-26 · 9y expired
What this patent protects
Devices and methods for treating intraocular pressure are disclosed. The devices include shunts (130) for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space.A swellable material (990) …
USPTO Abstract
Devices and methods for treating intraocular pressure are disclosed. The devices include shunts (130) for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space.A swellable material (990) can be positioned through lumen (136) at the outflow portion (134) in order to increase the outflow space.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.